TPM3-ALK and TPM4-ALK oncogenes in inflammatory myofibroblastic tumors

American Journal of Pathology

Volumn 157, Issue 2, 2000, Pages 377-384

  Lawrence, Brandon ^a   Perez Atayde, Antonio ^b   Hibbard, Michele K ^a   Rubin, Brian P ^a   Cin, Paola Dal ^a   Pinkus, Jack L ^a   Pinkus, Geraldine S ^a   Xiao, Sheng ^a   Yi, Eunhee S ^d   Fletcher, Christopher D M ^a   Fletcher, Jonathan A ^a,c  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b BOSTON CHILDREN S HOSPITAL   (United States)

^c DANA FARBER CANCER INSTITUTE   (United States)

^d UCSD MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANAPLASTIC LYMPHOMA KINASE; PROTEIN TYROSINE KINASE; TROPOMYOSIN; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CHILD; CHROMOSOME 2P; CHROMOSOME REARRANGEMENT; CLINICAL ARTICLE; DNA SEQUENCE; ENZYME ACTIVITY; FEMALE; FUSION GENE; HUMAN; IMMUNOHISTOCHEMISTRY; MALE; MESENCHYMOMA; NUCLEOTIDE SEQUENCE; ONCOGENE; PLASMA CELL GRANULOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION;

EID: 0033890820     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9440(10)64550-6     Document Type: Article

References (40)

1. Inflammatory fibrosarcoma of the mesentery and retroperitoneum. A tumor closely simulating inflammatory pseudotumor
2. Extrapulmonary inflammatory myofibroblastic tumor (inflammatory pseudotumor). A clinicopathologic and immunohistochemical study of 84 cases
3. Inflammatory myofibroblastic tumor, inflammatory fibrosarcoma, and related lesions: An historical review with differential diagnostic considerations
4. Inflammatory myofibroblastic tumor or inflammatory fibrosarcoma?
5. Omental-mesenteric inflammatory pseudotumor Cytogenetic demonstration of genetic changes and monoclonality in one tumor
6. Clonal changes in inflammatory pseudotumor of the lung: A case report
7. Pseudosarcomatous myofibroblastic tumor of the urinary bladder in children: A study of 11 cases with review of the literature An Intergroup Rhabdomyosarcoma Study
8. Inflammatory myofibroblastic tumor of bone: Report of two cases with evidence of clonal chromosomal changes
9. Inflammatory myofibroblastic tumor: Cytogenetic evidence supporting clonal origin
10. Recurrent involvement of 2p23 in inflammatory myofibroblastic tumors
11. Fusion of a kinase gene, ALK, to a nuoleolar protein gene, NPM, in non-Hodgkin's lymphoma
12. Detection of anaplastic lymphoma kinase (ALK) and nucleolar protein nucleophosmin (NPM)-ALK proteins in normal and neoplastic cells with the monoclonal antibody ALK1
13. ALK the chromosome 2 gene locus altered by the t(2;5) in non-Hodgkin's lymphoma, encodes a novel neural receptor tyrosine kinase that is highly related to leukocyte tyrosine kinase (LTK)
14. Molecular characterization of ALK, a receptor tyrosine kinase expressed specifically in the nervous system
15. Novel fluorescence in situ hybridization approaches in solid tumors: Characterization of frozen specimens, touch preparations, and cytologic preparations
16. A new fusion gene TPM3-ALK in anaplastic large cell lymphoma created by a (1;2)(q25;p23) translocation
17. A sequence analysis of the genomic regions involved in the rearrangements between TPM3 and NTRK1 genes producing TRK oncogenes in papillary thyroid carcinomas
18. Expression, cytoskeletal utilization and dimer formation of tropomyosin derived from retroviral-mediated cDNA transfer. Metabolism of tropomyosin from transduced cDNA
19. Human fibroblast tropomyosin isoforms: Characterization of cDNA clones and analysis of tropomyosin isoform expression in human tissues and in normal and transformed cells
20. A muscle-type tropomyosin in human fibroblasts: Evidence for expression by an alternative RNA splicing mechanism
21. Suppression of src-induced transformed phenotype by expression of tropomyosin-1
22. Ras- and Raf-induced down-modulation of non-muscle tropomyosin are MEK-independent
23. Suppression of tropomyosin synthesis, a common biochemical feature of oncogenesis by structurally diverse retroviral oncogenes
24. The monoclonal antibody ALK1 identifies a distinct morphological subtype of anaplastic large cell lymphoma associated with 2p23/ALK rearrangements
25. Lymphomas expressing ALK fusion protein(s) other than NPM-ALK
26. Biochemical detection of novel anaplastic lymphoma kinase proteins in tissue sections of anaplastic large cell lymphoma
27. Role of the nucleophosmin (NPM) portion of the non-Hodgkin's lymphoma-associated NPM-anaplastic lymphoma kinase fusion protein in oncogenesis
28. Anaplastic large cell lymphomas expressing the novel chimeric protein p80NPM/ALK a distinct clinicopathologic entity
29. ALK+ lymphoma: Clinico-pathological findings and outcome
30. Prognostic significance of anaplastic lymphoma kinase (ALK) protein expression in adults with anaplastic large cell lymphoma
31. Frequent expression of the NPM-ALK chimeric fusion protein in anaplastic large-cell lymphoma, lympho-histiocytic type
32. ALK-positive lymphoma: A single disease with a broad spectrum of morphology
33. t(1;2)(q21;p23) and t(2;3)(p23; q21): Two novel variant translocations of the t(2;5)(p23;q35) in anaplastic large cell lymphoma
34. Novel gain-of-function mutation of c-kit gene in gastrointestinal stromal tumors
35. Activating mutations of the c-kit proto-oncogene in a human mast cell leukemia cell line
36. Activating c-kit gene mutations in human germ cell tumors
37. c-kit point mutation of extracellular domain in patients with myeloproliferative disorders
38. A novel ETV6-NTRK3 gene fusion in congenital fibrosarcoma
39. Fusion of ETV6 to neurotrophin-3 receptor TRKC in acute myeloid leukemia with t(12;15)(p13;q25)